TapewireFind a company

person · Reporting owner

DIMICK NEIL F

Disclosed activity across 5 companies

Tapewire entity
74899
SEC CIK
0001248380

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
RESOURCES CONNECTION, INC.RGP · Entity 6553DirectorSeptember 26, 2025September 29, 2025
Viatris IncVTRS · Entity 3277DirectorMarch 21, 2022March 23, 2022

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

RESOURCES CONNECTION, INC.

Report date September 26, 2025 · Filed September 29, 2025

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Phantom StockSEC Table II · derivative / convertible securityDirect68,682 Reported balance After 2025-09-26 transaction · row 1 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 1 · 2025-09-26 · Grant · Acquired 929 · Balance 68,682

F1: Represents dividend equivalent phantom shares accrued on previously awarded phantom shares in accordance with the terms of the Directors Deferred Compensation Plan. Each share of phantom stock is the economic equivalent of one share of common stock. These shares of phantom stock will become payable in cash to the reporting person upon separation from service as a director in accordance with the reporting person's election under the Directors Deferred Compensation Plan.

Filing footnotes · ownership attribution and instrument terms

F1: Represents dividend equivalent phantom shares accrued on previously awarded phantom shares in accordance with the terms of the Directors Deferred Compensation Plan. Each share of phantom stock is the economic equivalent of one share of common stock. These shares of phantom stock will become payable in cash to the reporting person upon separation from service as a director in accordance with the reporting person's election under the Directors Deferred Compensation Plan.

Viatris Inc

Report date March 21, 2022 · Filed March 23, 2022

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect75,200 Reported balance After 2022-03-21 transaction · row 1 Account or security details depend on footnotes; rows are not merged.
1 source row

Row 1 · 2022-03-21 · Exercise / conversion · Acquired 166 · Balance 75,200

F1: Fractional shares have been rounded up in connection with the settlement described in footnote 2 pursuant to the terms of the restricted stock unit (RSU) award agreement under the Viatris Inc. 2020 Stock Incentive Plan.

F2: The total reported in Column 5 has been adjusted by 30 shares to correct an understatement of total holdings first reflected in the reporting person's Form 4 filed on March 4, 2022.

Dividend Equivalent UnitsSEC Table II · derivative / convertible securityDirect165.5224 Reported balance After 2022-03-21 transaction · row 2 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 2 · 2022-03-21 · Grant · Acquired 165.5224 · Balance 165.5224

F3: Represents dividend equivalent units (DEUs) that accrued with respect to RSUs previously granted on March 2, 2021. The DEUs vested upon accrual as the underlying RSUs had previously vested.

Dividend Equivalent UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00Direct0 Reported balance After 2022-03-21 transaction · row 3 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 3 · 2022-03-21 · Exercise / conversion · Disposed 165.5224 · Balance 0

F3: Represents dividend equivalent units (DEUs) that accrued with respect to RSUs previously granted on March 2, 2021. The DEUs vested upon accrual as the underlying RSUs had previously vested.

Filing footnotes · ownership attribution and instrument terms

F1: Fractional shares have been rounded up in connection with the settlement described in footnote 2 pursuant to the terms of the restricted stock unit (RSU) award agreement under the Viatris Inc. 2020 Stock Incentive Plan.

F2: The total reported in Column 5 has been adjusted by 30 shares to correct an understatement of total holdings first reflected in the reporting person's Form 4 filed on March 4, 2022.

F3: Represents dividend equivalent units (DEUs) that accrued with respect to RSUs previously granted on March 2, 2021. The DEUs vested upon accrual as the underlying RSUs had previously vested.

Past disclosures · reporting ended (3)

No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.

Alliance HealthCare Services, Inc

Report date August 21, 2017 · Filed August 22, 2017

Section 16 reporting ended · disclosed 2017-08-22. Current position is not established by this disclosure.

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect0 Reported balance After 2017-08-21 transaction · row 1
1 source row

Row 1 · 2017-08-21 · Disposition to issuer · Disposed 70,817 · Balance 0

F1: Disposed of pursuant to the closing of the transactions contemplated by that certain Agreement and Plan of Merger, dated as of April 10, 2017 by and among the Issuer, Tahoe Investment Group Co., Ltd., THAIHOT Investment Company Limited, THAIHOT Investment Company US Limited and Alliance Healthcare Services Merger Sub Limited. Each share of Issuer common stock held by the reporting person was cancelled in the merger and converted into the right to receive $13.25 in cash per share, without interest and less any applicable withholding taxes.

Filing footnotes · ownership attribution and instrument terms

F1: Disposed of pursuant to the closing of the transactions contemplated by that certain Agreement and Plan of Merger, dated as of April 10, 2017 by and among the Issuer, Tahoe Investment Group Co., Ltd., THAIHOT Investment Company Limited, THAIHOT Investment Company US Limited and Alliance Healthcare Services Merger Sub Limited. Each share of Issuer common stock held by the reporting person was cancelled in the merger and converted into the right to receive $13.25 in cash per share, without interest and less any applicable withholding taxes.

Mylan II B.V.

Report date November 16, 2020 · Filed November 18, 2020

Section 16 reporting ended · disclosed 2020-11-18. Current position is not established by this disclosure.

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Ordinary SharesSEC Table I · non-derivativeDirect0 Reported balance After 2020-11-16 transaction · row 1 Account or security details depend on footnotes; rows are not merged.
1 source row

Row 1 · 2020-11-16 · Disposition to issuer · Disposed 51,263 · Balance 0

F1: On November 16, 2020, Mylan N.V. ("Mylan") completed the transaction pursuant to which Mylan combined with Pfizer Inc.'s ("Pfizer") Upjohn business (the "Upjohn Business") in a Reverse Morris Trust transaction (the "Combination") and Upjohn Inc. ("Upjohn") became the parent entity of the combined Upjohn Business and Mylan business and was renamed "Viatris Inc." ("Viatris"). Pursuant to the terms of the Business Combination Agreement (as amended), dated July 29, 2019, by and among Mylan, Pfizer, Upjohn and certain other affiliated entities, Upjohn and Mylan effected the Combination through a series of transactions, including that (1) Mylan merged with and into Mylan II B.V. with Mylan II B.V. surviving the merger as the legal successor of Mylan and (2) each holder of Mylan ordinary shares received one share of Viatris common stock for each Mylan ordinary share held by such holder (subject to any required withholding tax).

F2: Represents ordinary shares of Mylan that were exchanged on a one-for-one basis for shares of Viatris common stock in connection with the Combination. On the effective date of the Combination, the closing price of a Mylan ordinary share was $15.85 per share.

Non-Employee Director Stock Option - Right to BuySEC Table II · derivative / convertible security · Conversion / exercise price $45.72 · Expires 2024-04-11Direct0 Reported balance After 2020-11-16 transaction · row 2 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 2 · 2020-11-16 · Disposition to issuer · Disposed 2,974 · Balance 0

F3: Represents stock options to acquire Mylan ordinary shares that were exchanged for stock options to acquire Viatris common stock having substantially the same terms in connection with the Combination.

F4: These options vested on April 11, 2015.

Non-Employee Director Stock Option - Right to BuySEC Table II · derivative / convertible security · Conversion / exercise price $50.66 · Expires 2025-11-17Direct0 Reported balance After 2020-11-16 transaction · row 3 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 3 · 2020-11-16 · Disposition to issuer · Disposed 2,603 · Balance 0

F3: Represents stock options to acquire Mylan ordinary shares that were exchanged for stock options to acquire Viatris common stock having substantially the same terms in connection with the Combination.

F5: These options vested on May 1, 2016.

Non-Employee Director Stock Option - Right to BuySEC Table II · derivative / convertible security · Conversion / exercise price $46.27 · Expires 2026-02-17Direct0 Reported balance After 2020-11-16 transaction · row 4 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 4 · 2020-11-16 · Disposition to issuer · Disposed 2,788 · Balance 0

F3: Represents stock options to acquire Mylan ordinary shares that were exchanged for stock options to acquire Viatris common stock having substantially the same terms in connection with the Combination.

F6: These options vested on February 17, 2017.

Non-Employee Director Stock Option - Right to BuySEC Table II · derivative / convertible security · Conversion / exercise price $45.18 · Expires 2027-03-03Direct0 Reported balance After 2020-11-16 transaction · row 5 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 5 · 2020-11-16 · Disposition to issuer · Disposed 2,928 · Balance 0

F3: Represents stock options to acquire Mylan ordinary shares that were exchanged for stock options to acquire Viatris common stock having substantially the same terms in connection with the Combination.

F7: These options vested on March 3, 2018.

Non-Employee Director Stock Option - Right to BuySEC Table II · derivative / convertible security · Conversion / exercise price $40.97 · Expires 2028-03-02Direct0 Reported balance After 2020-11-16 transaction · row 6 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 6 · 2020-11-16 · Disposition to issuer · Disposed 2,984 · Balance 0

F3: Represents stock options to acquire Mylan ordinary shares that were exchanged for stock options to acquire Viatris common stock having substantially the same terms in connection with the Combination.

F8: These options vested on March 2, 2019.

Non-Employee Director Stock Option - Right to BuySEC Table II · derivative / convertible security · Conversion / exercise price $27.45 · Expires 2029-03-01Direct0 Reported balance After 2020-11-16 transaction · row 7 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 7 · 2020-11-16 · Disposition to issuer · Disposed 4,352 · Balance 0

F3: Represents stock options to acquire Mylan ordinary shares that were exchanged for stock options to acquire Viatris common stock having substantially the same terms in connection with the Combination.

F9: These options vested on March 2, 2020.

Non-Employee Director Stock Option - Right to BuySEC Table II · derivative / convertible security · Conversion / exercise price $17.48 · Expires 2030-03-02Direct0 Reported balance After 2020-11-16 transaction · row 8 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 8 · 2020-11-16 · Disposition to issuer · Disposed 6,151 · Balance 0

F3: Represents stock options to acquire Mylan ordinary shares that were exchanged for stock options to acquire Viatris common stock having substantially the same terms in connection with the Combination.

F10: These options will vest on March 2, 2021.

Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00Direct0 Reported balance After 2020-11-16 transaction · row 9 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 9 · 2020-11-16 · Disposition to issuer · Disposed 9,440 · Balance 0

F11: Represents restricted stock units ("RSUs") of Mylan that were exchanged on a one-for-one basis for RSUs of Viatris having substantially the same terms in connection with the Combination.

F12: Each RSU represents the right to receive one ordinary share of Mylan. The RSUs will vest on March 2, 2021.

Filing footnotes · ownership attribution and instrument terms

F1: On November 16, 2020, Mylan N.V. ("Mylan") completed the transaction pursuant to which Mylan combined with Pfizer Inc.'s ("Pfizer") Upjohn business (the "Upjohn Business") in a Reverse Morris Trust transaction (the "Combination") and Upjohn Inc. ("Upjohn") became the parent entity of the combined Upjohn Business and Mylan business and was renamed "Viatris Inc." ("Viatris"). Pursuant to the terms of the Business Combination Agreement (as amended), dated July 29, 2019, by and among Mylan, Pfizer, Upjohn and certain other affiliated entities, Upjohn and Mylan effected the Combination through a series of transactions, including that (1) Mylan merged with and into Mylan II B.V. with Mylan II B.V. surviving the merger as the legal successor of Mylan and (2) each holder of Mylan ordinary shares received one share of Viatris common stock for each Mylan ordinary share held by such holder (subject to any required withholding tax).

F2: Represents ordinary shares of Mylan that were exchanged on a one-for-one basis for shares of Viatris common stock in connection with the Combination. On the effective date of the Combination, the closing price of a Mylan ordinary share was $15.85 per share.

F3: Represents stock options to acquire Mylan ordinary shares that were exchanged for stock options to acquire Viatris common stock having substantially the same terms in connection with the Combination.

F4: These options vested on April 11, 2015.

F5: These options vested on May 1, 2016.

F6: These options vested on February 17, 2017.

F7: These options vested on March 3, 2018.

F8: These options vested on March 2, 2019.

F9: These options vested on March 2, 2020.

F10: These options will vest on March 2, 2021.

F11: Represents restricted stock units ("RSUs") of Mylan that were exchanged on a one-for-one basis for RSUs of Viatris having substantially the same terms in connection with the Combination.

F12: Each RSU represents the right to receive one ordinary share of Mylan. The RSUs will vest on March 2, 2021.

WebMD Health Corp.

Report date September 15, 2017 · Filed September 15, 2017

Section 16 reporting ended · disclosed 2017-09-15. Current position is not established by this disclosure.

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect0 Reported balance After 2017-09-15 transaction · row 1
1 source row

Row 1 · 2017-09-15 · Other · Disposed 13,862 · Balance 0

F1: Sold in a tender offer made by Diagnosis Merger Sub, Inc., a Delaware Corporation ("Purchaser") and a wholly-owned subsidiary of MH Sub I, LLC, a Delaware limited liability company ("Parent"), to purchase all of the issued and outstanding shares of common stock of WebMD Health Corp., a Delaware corporation ("WebMD"), for $66.50 per share, pursuant to the terms of that certain Agreement and Plan of Merger, dated as of July 24, 2017, by and among WebMD, Purchaser, and Parent (the "Merger Agreement").

Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $41.07 · Expires 2018-01-01Direct0 Reported balance After 2017-09-15 transaction · row 2 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 2 · 2017-09-15 · Disposition to issuer · Disposed 13,200 · Balance 0

F2: On September 15, 2017, the merger transaction (the "Merger") contemplated by the Merger Agreement was completed and WebMD was acquired by the Purchaser and ceased to be a public company. Pursuant to the Merger Agreement, each option that was vested and exercisable immediately prior to completion of the Merger, or that vested upon completion of the Merger in accordance with its terms, was automatically cancelled in exchange for the right of the holder to receive an amount in cash equal to the excess of $66.50 over the exercise price of each such option. In connection with the completion of the Merger, each unvested option held by the Reporting Person fully accelerated. The Reporting Person no longer owns any securities issued by WebMD.

Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $23.54 · Expires 2019-01-01Direct0 Reported balance After 2017-09-15 transaction · row 3 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 3 · 2017-09-15 · Disposition to issuer · Disposed 8,888 · Balance 0

F2: On September 15, 2017, the merger transaction (the "Merger") contemplated by the Merger Agreement was completed and WebMD was acquired by the Purchaser and ceased to be a public company. Pursuant to the Merger Agreement, each option that was vested and exercisable immediately prior to completion of the Merger, or that vested upon completion of the Merger in accordance with its terms, was automatically cancelled in exchange for the right of the holder to receive an amount in cash equal to the excess of $66.50 over the exercise price of each such option. In connection with the completion of the Merger, each unvested option held by the Reporting Person fully accelerated. The Reporting Person no longer owns any securities issued by WebMD.

Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $38.49 · Expires 2020-01-01Direct0 Reported balance After 2017-09-15 transaction · row 4 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 4 · 2017-09-15 · Disposition to issuer · Disposed 13,200 · Balance 0

F2: On September 15, 2017, the merger transaction (the "Merger") contemplated by the Merger Agreement was completed and WebMD was acquired by the Purchaser and ceased to be a public company. Pursuant to the Merger Agreement, each option that was vested and exercisable immediately prior to completion of the Merger, or that vested upon completion of the Merger in accordance with its terms, was automatically cancelled in exchange for the right of the holder to receive an amount in cash equal to the excess of $66.50 over the exercise price of each such option. In connection with the completion of the Merger, each unvested option held by the Reporting Person fully accelerated. The Reporting Person no longer owns any securities issued by WebMD.

Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $37.55 · Expires 2022-01-01Direct0 Reported balance After 2017-09-15 transaction · row 5 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 5 · 2017-09-15 · Disposition to issuer · Disposed 13,200 · Balance 0

F2: On September 15, 2017, the merger transaction (the "Merger") contemplated by the Merger Agreement was completed and WebMD was acquired by the Purchaser and ceased to be a public company. Pursuant to the Merger Agreement, each option that was vested and exercisable immediately prior to completion of the Merger, or that vested upon completion of the Merger in accordance with its terms, was automatically cancelled in exchange for the right of the holder to receive an amount in cash equal to the excess of $66.50 over the exercise price of each such option. In connection with the completion of the Merger, each unvested option held by the Reporting Person fully accelerated. The Reporting Person no longer owns any securities issued by WebMD.

Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $14.34 · Expires 2023-01-01Direct0 Reported balance After 2017-09-15 transaction · row 6 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 6 · 2017-09-15 · Disposition to issuer · Disposed 13,200 · Balance 0

F2: On September 15, 2017, the merger transaction (the "Merger") contemplated by the Merger Agreement was completed and WebMD was acquired by the Purchaser and ceased to be a public company. Pursuant to the Merger Agreement, each option that was vested and exercisable immediately prior to completion of the Merger, or that vested upon completion of the Merger in accordance with its terms, was automatically cancelled in exchange for the right of the holder to receive an amount in cash equal to the excess of $66.50 over the exercise price of each such option. In connection with the completion of the Merger, each unvested option held by the Reporting Person fully accelerated. The Reporting Person no longer owns any securities issued by WebMD.

Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $39.50 · Expires 2024-01-01Direct0 Reported balance After 2017-09-15 transaction · row 7 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 7 · 2017-09-15 · Disposition to issuer · Disposed 13,200 · Balance 0

F2: On September 15, 2017, the merger transaction (the "Merger") contemplated by the Merger Agreement was completed and WebMD was acquired by the Purchaser and ceased to be a public company. Pursuant to the Merger Agreement, each option that was vested and exercisable immediately prior to completion of the Merger, or that vested upon completion of the Merger in accordance with its terms, was automatically cancelled in exchange for the right of the holder to receive an amount in cash equal to the excess of $66.50 over the exercise price of each such option. In connection with the completion of the Merger, each unvested option held by the Reporting Person fully accelerated. The Reporting Person no longer owns any securities issued by WebMD.

Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $39.55 · Expires 2025-01-01Direct0 Reported balance After 2017-09-15 transaction · row 8 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 8 · 2017-09-15 · Disposition to issuer · Disposed 13,200 · Balance 0

F2: On September 15, 2017, the merger transaction (the "Merger") contemplated by the Merger Agreement was completed and WebMD was acquired by the Purchaser and ceased to be a public company. Pursuant to the Merger Agreement, each option that was vested and exercisable immediately prior to completion of the Merger, or that vested upon completion of the Merger in accordance with its terms, was automatically cancelled in exchange for the right of the holder to receive an amount in cash equal to the excess of $66.50 over the exercise price of each such option. In connection with the completion of the Merger, each unvested option held by the Reporting Person fully accelerated. The Reporting Person no longer owns any securities issued by WebMD.

Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $48.30 · Expires 2026-01-01Direct0 Reported balance After 2017-09-15 transaction · row 9 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 9 · 2017-09-15 · Disposition to issuer · Disposed 13,200 · Balance 0

F2: On September 15, 2017, the merger transaction (the "Merger") contemplated by the Merger Agreement was completed and WebMD was acquired by the Purchaser and ceased to be a public company. Pursuant to the Merger Agreement, each option that was vested and exercisable immediately prior to completion of the Merger, or that vested upon completion of the Merger in accordance with its terms, was automatically cancelled in exchange for the right of the holder to receive an amount in cash equal to the excess of $66.50 over the exercise price of each such option. In connection with the completion of the Merger, each unvested option held by the Reporting Person fully accelerated. The Reporting Person no longer owns any securities issued by WebMD.

Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $49.57 · Expires 2027-01-01Direct0 Reported balance After 2017-09-15 transaction · row 10 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 10 · 2017-09-15 · Disposition to issuer · Disposed 13,200 · Balance 0

F2: On September 15, 2017, the merger transaction (the "Merger") contemplated by the Merger Agreement was completed and WebMD was acquired by the Purchaser and ceased to be a public company. Pursuant to the Merger Agreement, each option that was vested and exercisable immediately prior to completion of the Merger, or that vested upon completion of the Merger in accordance with its terms, was automatically cancelled in exchange for the right of the holder to receive an amount in cash equal to the excess of $66.50 over the exercise price of each such option. In connection with the completion of the Merger, each unvested option held by the Reporting Person fully accelerated. The Reporting Person no longer owns any securities issued by WebMD.

Filing footnotes · ownership attribution and instrument terms

F1: Sold in a tender offer made by Diagnosis Merger Sub, Inc., a Delaware Corporation ("Purchaser") and a wholly-owned subsidiary of MH Sub I, LLC, a Delaware limited liability company ("Parent"), to purchase all of the issued and outstanding shares of common stock of WebMD Health Corp., a Delaware corporation ("WebMD"), for $66.50 per share, pursuant to the terms of that certain Agreement and Plan of Merger, dated as of July 24, 2017, by and among WebMD, Purchaser, and Parent (the "Merger Agreement").

F2: On September 15, 2017, the merger transaction (the "Merger") contemplated by the Merger Agreement was completed and WebMD was acquired by the Purchaser and ceased to be a public company. Pursuant to the Merger Agreement, each option that was vested and exercisable immediately prior to completion of the Merger, or that vested upon completion of the Merger in accordance with its terms, was automatically cancelled in exchange for the right of the holder to receive an amount in cash equal to the excess of $66.50 over the exercise price of each such option. In connection with the completion of the Merger, each unvested option held by the Reporting Person fully accelerated. The Reporting Person no longer owns any securities issued by WebMD.

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
September 26, 2025 Filed Sep 29, 2025 20:19 UTC RESOURCES CONNECTION, INC. RGP · Entity 6553 GrantPhantom Stock · Derivative 929 $0.00 $0.00
Disclosure

SEC source: 0001248380-25-000005 · edgardoc.xml · derivative · entry 1

DIMICK NEIL F · CIK 0001248380 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 68,682

Underlying: Common Stock · 929 shares

Expires not disclosed

F1 · derivative.exercise_price: Represents dividend equivalent phantom shares accrued on previously awarded phantom shares in accordance with the terms of the Directors Deferred Compensation Plan. Each share of phantom stock is the economic equivalent of one share of common stock. These shares of phantom stock will become payable in cash to the reporting person upon separation from service as a director in accordance with the reporting person's election under the Directors Deferred Compensation Plan.

F1 · derivative.exercise_date: Represents dividend equivalent phantom shares accrued on previously awarded phantom shares in accordance with the terms of the Directors Deferred Compensation Plan. Each share of phantom stock is the economic equivalent of one share of common stock. These shares of phantom stock will become payable in cash to the reporting person upon separation from service as a director in accordance with the reporting person's election under the Directors Deferred Compensation Plan.

F1 · derivative.expiration_date: Represents dividend equivalent phantom shares accrued on previously awarded phantom shares in accordance with the terms of the Directors Deferred Compensation Plan. Each share of phantom stock is the economic equivalent of one share of common stock. These shares of phantom stock will become payable in cash to the reporting person upon separation from service as a director in accordance with the reporting person's election under the Directors Deferred Compensation Plan.

Read SEC document
July 21, 2025 Filed Jul 23, 2025 20:35 UTC RESOURCES CONNECTION, INC. RGP · Entity 6553 GrantPhantom Stock · Derivative 895 $0.00 $0.00
Disclosure

SEC source: 0001084765-25-000100 · edgardoc.xml · derivative · entry 1

DIMICK NEIL F · CIK 0001248380 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 67,753

Underlying: Common Stock · 895 shares

Expires not disclosed

F1 · derivative.exercise_price: Represents dividend equivalent phantom shares accrued on previously awarded phantom shares in accordance with the terms of the Directors Deferred Compensation Plan. Each share of phantom stock is the economic equivalent of one share of common stock. These shares of phantom stock will become payable in cash to the reporting person upon separation from service as a director in accordance with the reporting person's election under the Directors Deferred Compensation Plan.

F1 · derivative.exercise_date: Represents dividend equivalent phantom shares accrued on previously awarded phantom shares in accordance with the terms of the Directors Deferred Compensation Plan. Each share of phantom stock is the economic equivalent of one share of common stock. These shares of phantom stock will become payable in cash to the reporting person upon separation from service as a director in accordance with the reporting person's election under the Directors Deferred Compensation Plan.

F1 · derivative.expiration_date: Represents dividend equivalent phantom shares accrued on previously awarded phantom shares in accordance with the terms of the Directors Deferred Compensation Plan. Each share of phantom stock is the economic equivalent of one share of common stock. These shares of phantom stock will become payable in cash to the reporting person upon separation from service as a director in accordance with the reporting person's election under the Directors Deferred Compensation Plan.

Read SEC document
March 14, 2025 Filed Apr 3, 2025 21:08 UTC RESOURCES CONNECTION, INC. RGP · Entity 6553 GrantPhantom Stock · Derivative 1,327 $0.00 $0.00
Disclosure

SEC source: 0001084765-25-000045 · edgardoc.xml · derivative · entry 1

DIMICK NEIL F · CIK 0001248380 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 66,858

Underlying: Common Stock · 1,327 shares

Expires not disclosed

F1 · derivative.exercise_price: Represents dividend equivalent phantom shares accrued on previously awarded phantom shares in accordance with the terms of the Directors Deferred Compensation Plan. Each share of phantom stock is the economic equivalent of one share of common stock. These shares of phantom stock will become payable in cash to the reporting person upon separation from service as a director in accordance with the reporting person's election under the Directors Deferred Compensation Plan.

F1 · derivative.exercise_date: Represents dividend equivalent phantom shares accrued on previously awarded phantom shares in accordance with the terms of the Directors Deferred Compensation Plan. Each share of phantom stock is the economic equivalent of one share of common stock. These shares of phantom stock will become payable in cash to the reporting person upon separation from service as a director in accordance with the reporting person's election under the Directors Deferred Compensation Plan.

F1 · derivative.expiration_date: Represents dividend equivalent phantom shares accrued on previously awarded phantom shares in accordance with the terms of the Directors Deferred Compensation Plan. Each share of phantom stock is the economic equivalent of one share of common stock. These shares of phantom stock will become payable in cash to the reporting person upon separation from service as a director in accordance with the reporting person's election under the Directors Deferred Compensation Plan.

Read SEC document
January 02, 2025 Filed Jan 3, 2025 21:31 UTC RESOURCES CONNECTION, INC. RGP · Entity 6553 GrantPhantom Stock · Derivative 11,467 $0.00 $0.00
Disclosure

SEC source: 0001084765-25-000021 · edgardoc.xml · derivative · entry 1

DIMICK NEIL F · CIK 0001248380 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 65,531

Underlying: Common Stock · 11,467 shares

Expires not disclosed

F1 · derivative.exercise_price: Award vests 25% after one year and 25% each year thereafter for the next three years. Represents credit of deferred compensation to reporting person's deferred stock account under the Directors Deferred Compensation Plan. Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock to the extent then-vested become payable in cash to the reporting person upon separation from service as a director in accordance with the reporting person's election under the Directors Deferred Compensation Plan.

F1 · derivative.exercise_date: Award vests 25% after one year and 25% each year thereafter for the next three years. Represents credit of deferred compensation to reporting person's deferred stock account under the Directors Deferred Compensation Plan. Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock to the extent then-vested become payable in cash to the reporting person upon separation from service as a director in accordance with the reporting person's election under the Directors Deferred Compensation Plan.

F1 · derivative.expiration_date: Award vests 25% after one year and 25% each year thereafter for the next three years. Represents credit of deferred compensation to reporting person's deferred stock account under the Directors Deferred Compensation Plan. Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock to the extent then-vested become payable in cash to the reporting person upon separation from service as a director in accordance with the reporting person's election under the Directors Deferred Compensation Plan.

Read SEC document
December 16, 2024 Filed Dec 17, 2024 23:04 UTC RESOURCES CONNECTION, INC. RGP · Entity 6553 GrantPhantom Stock · Derivative 901 $0.00 $0.00
Disclosure

SEC source: 0001084765-24-000178 · edgardoc.xml · derivative · entry 1

DIMICK NEIL F · CIK 0001248380 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 54,064

Underlying: Common Stock · 901 shares

Expires not disclosed

F1 · derivative.exercise_price: Represents dividend equivalent phantom shares accrued on previously awarded phantom shares in accordance with the terms of the Directors Deferred Compensation Plan. Each share of phantom stock is the economic equivalent of one share of common stock. These shares of phantom stock will become payable in cash to the reporting person upon separation from service as a director in accordance with the reporting person's election under the Directors Deferred Compensation Plan.

F1 · derivative.exercise_date: Represents dividend equivalent phantom shares accrued on previously awarded phantom shares in accordance with the terms of the Directors Deferred Compensation Plan. Each share of phantom stock is the economic equivalent of one share of common stock. These shares of phantom stock will become payable in cash to the reporting person upon separation from service as a director in accordance with the reporting person's election under the Directors Deferred Compensation Plan.

F1 · derivative.expiration_date: Represents dividend equivalent phantom shares accrued on previously awarded phantom shares in accordance with the terms of the Directors Deferred Compensation Plan. Each share of phantom stock is the economic equivalent of one share of common stock. These shares of phantom stock will become payable in cash to the reporting person upon separation from service as a director in accordance with the reporting person's election under the Directors Deferred Compensation Plan.

Read SEC document
September 20, 2024 Filed Sep 24, 2024 21:03 UTC RESOURCES CONNECTION, INC. RGP · Entity 6553 GrantPhantom Stock · Derivative 736 $0.00 $0.00
Disclosure

SEC source: 0001084765-24-000132 · edgardoc.xml · derivative · entry 1

DIMICK NEIL F · CIK 0001248380 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 53,163

Underlying: Common Stock · 736 shares

Expires not disclosed

F1 · derivative.exercise_price: Represents dividend equivalent phantom shares accrued on previously awarded phantom shares in accordance with the terms of the Directors Deferred Compensation Plan. Each share of phantom stock is the economic equivalent of one share of common stock. These shares of phantom stock will become payable in cash to the reporting person upon separation from service as a director in accordance with the reporting person's election under the Directors Deferred Compensation Plan.

F1 · derivative.exercise_date: Represents dividend equivalent phantom shares accrued on previously awarded phantom shares in accordance with the terms of the Directors Deferred Compensation Plan. Each share of phantom stock is the economic equivalent of one share of common stock. These shares of phantom stock will become payable in cash to the reporting person upon separation from service as a director in accordance with the reporting person's election under the Directors Deferred Compensation Plan.

F1 · derivative.expiration_date: Represents dividend equivalent phantom shares accrued on previously awarded phantom shares in accordance with the terms of the Directors Deferred Compensation Plan. Each share of phantom stock is the economic equivalent of one share of common stock. These shares of phantom stock will become payable in cash to the reporting person upon separation from service as a director in accordance with the reporting person's election under the Directors Deferred Compensation Plan.

Read SEC document
June 13, 2024 Filed Jun 14, 2024 20:13 UTC RESOURCES CONNECTION, INC. RGP · Entity 6553 GrantPhantom Stock · Derivative 673 $0.00 $0.00
Disclosure

SEC source: 0001084765-24-000080 · edgardoc.xml · derivative · entry 1

DIMICK NEIL F · CIK 0001248380 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 52,427

Underlying: Common Stock · 673 shares

Expires not disclosed

F1 · derivative.exercise_price: Represents dividend equivalent phantom shares accrued on previously awarded phantom shares in accordance with the terms of the Directors Deferred Compensation Plan. Each share of phantom stock is the economic equivalent of one share of common stock. These shares of phantom stock will become payable in cash to the reporting person upon separation from service as a director in accordance with the reporting person's election under the Directors Deferred Compensation Plan.

F1 · derivative.exercise_date: Represents dividend equivalent phantom shares accrued on previously awarded phantom shares in accordance with the terms of the Directors Deferred Compensation Plan. Each share of phantom stock is the economic equivalent of one share of common stock. These shares of phantom stock will become payable in cash to the reporting person upon separation from service as a director in accordance with the reporting person's election under the Directors Deferred Compensation Plan.

F1 · derivative.expiration_date: Represents dividend equivalent phantom shares accrued on previously awarded phantom shares in accordance with the terms of the Directors Deferred Compensation Plan. Each share of phantom stock is the economic equivalent of one share of common stock. These shares of phantom stock will become payable in cash to the reporting person upon separation from service as a director in accordance with the reporting person's election under the Directors Deferred Compensation Plan.

Read SEC document
March 14, 2024 Filed Mar 18, 2024 20:38 UTC RESOURCES CONNECTION, INC. RGP · Entity 6553 GrantPhantom Stock · Derivative 550 $0.00 $0.00
Disclosure

SEC source: 0001084765-24-000031 · edgardoc.xml · derivative · entry 1

DIMICK NEIL F · CIK 0001248380 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 51,754

Underlying: Common Stock · 550 shares

Expires not disclosed

F1 · derivative.exercise_price: Represents dividend equivalent phantom shares accrued on previously awarded phantom shares in accordance with the terms of the Directors Deferred Compensation Plan. Each share of phantom stock is the economic equivalent of one share of common stock. These shares of phantom stock will become payable in cash to the reporting person upon separation from service as a director in accordance with the reporting person's election under the Directors Deferred Compensation Plan.

F1 · derivative.exercise_date: Represents dividend equivalent phantom shares accrued on previously awarded phantom shares in accordance with the terms of the Directors Deferred Compensation Plan. Each share of phantom stock is the economic equivalent of one share of common stock. These shares of phantom stock will become payable in cash to the reporting person upon separation from service as a director in accordance with the reporting person's election under the Directors Deferred Compensation Plan.

F1 · derivative.expiration_date: Represents dividend equivalent phantom shares accrued on previously awarded phantom shares in accordance with the terms of the Directors Deferred Compensation Plan. Each share of phantom stock is the economic equivalent of one share of common stock. These shares of phantom stock will become payable in cash to the reporting person upon separation from service as a director in accordance with the reporting person's election under the Directors Deferred Compensation Plan.

Read SEC document
January 02, 2024 Filed Jan 3, 2024 22:09 UTC RESOURCES CONNECTION, INC. RGP · Entity 6553 GrantPhantom Stock · Derivative 7,153 $0.00 $0.00
Disclosure

SEC source: 0001084765-24-000015 · edgardoc.xml · derivative · entry 1

DIMICK NEIL F · CIK 0001248380 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 51,204

Underlying: Common Stock · 7,153 shares

Expires not disclosed

F1 · derivative.exercise_price: Award vests 25% after one year and 25% each year thereafter for the next three years. Represents credit of deferred compensation to reporting person's deferred stock account under the Directors Deferred Compensation Plan. Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock to the extent then-vested become payable in cash to the reporting person upon separation from service as a director in accordance with the reporting person's election under the Directors Deferred Compensation Plan.

F1 · derivative.exercise_date: Award vests 25% after one year and 25% each year thereafter for the next three years. Represents credit of deferred compensation to reporting person's deferred stock account under the Directors Deferred Compensation Plan. Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock to the extent then-vested become payable in cash to the reporting person upon separation from service as a director in accordance with the reporting person's election under the Directors Deferred Compensation Plan.

F1 · derivative.expiration_date: Award vests 25% after one year and 25% each year thereafter for the next three years. Represents credit of deferred compensation to reporting person's deferred stock account under the Directors Deferred Compensation Plan. Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock to the extent then-vested become payable in cash to the reporting person upon separation from service as a director in accordance with the reporting person's election under the Directors Deferred Compensation Plan.

Read SEC document
December 14, 2023 Filed Dec 15, 2023 22:11 UTC RESOURCES CONNECTION, INC. RGP · Entity 6553 GrantPhantom Stock · Derivative 419 $0.00 $0.00
Disclosure

SEC source: 0001084765-23-000059 · edgardoc.xml · derivative · entry 1

DIMICK NEIL F · CIK 0001248380 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 44,051

Underlying: Common Stock · 419 shares

Expires not disclosed

F1 · derivative.exercise_price: Represents dividend equivalent phantom shares accrued on previously awarded phantom shares in accordance with the terms of the Directors Deferred Compensation Plan. Each share of phantom stock is the economic equivalent of one share of common stock. These shares of phantom stock will become payable in cash to the reporting person upon separation from service as a director in accordance with the reporting person's election under the Directors Deferred Compensation Plan.

F1 · derivative.exercise_date: Represents dividend equivalent phantom shares accrued on previously awarded phantom shares in accordance with the terms of the Directors Deferred Compensation Plan. Each share of phantom stock is the economic equivalent of one share of common stock. These shares of phantom stock will become payable in cash to the reporting person upon separation from service as a director in accordance with the reporting person's election under the Directors Deferred Compensation Plan.

F1 · derivative.expiration_date: Represents dividend equivalent phantom shares accrued on previously awarded phantom shares in accordance with the terms of the Directors Deferred Compensation Plan. Each share of phantom stock is the economic equivalent of one share of common stock. These shares of phantom stock will become payable in cash to the reporting person upon separation from service as a director in accordance with the reporting person's election under the Directors Deferred Compensation Plan.

Read SEC document
September 21, 2023 Filed Sep 22, 2023 21:52 UTC RESOURCES CONNECTION, INC. RGP · Entity 6553 GrantPhantom Stock · Derivative 394 $0.00 $0.00
Disclosure

SEC source: 0001084765-23-000032 · edgardoc.xml · derivative · entry 1

DIMICK NEIL F · CIK 0001248380 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 43,632

Underlying: Common Stock · 394 shares

Expires not disclosed

F1 · derivative.exercise_price: Represents dividend equivalent phantom shares accrued on previously awarded phantom shares in accordance with the terms of the Directors Deferred Compensation Plan. Each share of phantom stock is the economic equivalent of one share of common stock. These shares of phantom stock will become payable in cash to the reporting person upon separation from service as a director in accordance with the reporting person's election under the Directors Deferred Compensation Plan.

F1 · derivative.exercise_date: Represents dividend equivalent phantom shares accrued on previously awarded phantom shares in accordance with the terms of the Directors Deferred Compensation Plan. Each share of phantom stock is the economic equivalent of one share of common stock. These shares of phantom stock will become payable in cash to the reporting person upon separation from service as a director in accordance with the reporting person's election under the Directors Deferred Compensation Plan.

F1 · derivative.expiration_date: Represents dividend equivalent phantom shares accrued on previously awarded phantom shares in accordance with the terms of the Directors Deferred Compensation Plan. Each share of phantom stock is the economic equivalent of one share of common stock. These shares of phantom stock will become payable in cash to the reporting person upon separation from service as a director in accordance with the reporting person's election under the Directors Deferred Compensation Plan.

Read SEC document
June 15, 2023 Filed Jun 16, 2023 21:56 UTC RESOURCES CONNECTION, INC. RGP · Entity 6553 GrantPhantom Stock · Derivative 373 $0.00 $0.00
Disclosure

SEC source: 0001248380-23-000006 · edgardoc.xml · derivative · entry 1

DIMICK NEIL F · CIK 0001248380 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 43,238

Underlying: Common Stock · 373 shares

Expires not disclosed

F1 · derivative.exercise_price: Represents dividend equivalent phantom shares accrued on previously awarded phantom shares in accordance with the terms of the Directors Deferred Compensation Plan. Each share of phantom stock is the economic equivalent of one share of common stock. These shares of phantom stock will become payable in cash to the reporting person upon separation from service as a director in accordance with the reporting person's election under the Directors Deferred Compensation Plan.

F1 · derivative.exercise_date: Represents dividend equivalent phantom shares accrued on previously awarded phantom shares in accordance with the terms of the Directors Deferred Compensation Plan. Each share of phantom stock is the economic equivalent of one share of common stock. These shares of phantom stock will become payable in cash to the reporting person upon separation from service as a director in accordance with the reporting person's election under the Directors Deferred Compensation Plan.

F1 · derivative.expiration_date: Represents dividend equivalent phantom shares accrued on previously awarded phantom shares in accordance with the terms of the Directors Deferred Compensation Plan. Each share of phantom stock is the economic equivalent of one share of common stock. These shares of phantom stock will become payable in cash to the reporting person upon separation from service as a director in accordance with the reporting person's election under the Directors Deferred Compensation Plan.

Read SEC document
March 16, 2023 Filed Mar 17, 2023 21:34 UTC RESOURCES CONNECTION, INC. RGP · Entity 6553 GrantPhantom Stock · Derivative 332 $0.00 $0.00
Disclosure

SEC source: 0001248380-23-000004 · edgardoc.xml · derivative · entry 1

DIMICK NEIL F · CIK 0001248380 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 42,865

Underlying: Common Stock · 332 shares

Expires not disclosed

F1 · derivative.exercise_price: Represents dividend equivalent phantom shares accrued on previously awarded phantom shares in accordance with the terms of the Directors Deferred Compensation Plan. Each share of phantom stock is the economic equivalent of one share of common stock. These shares of phantom stock will become payable in cash to the reporting person upon separation from service as a director in accordance with the reporting person's election under the Directors Deferred Compensation Plan.

F1 · derivative.exercise_date: Represents dividend equivalent phantom shares accrued on previously awarded phantom shares in accordance with the terms of the Directors Deferred Compensation Plan. Each share of phantom stock is the economic equivalent of one share of common stock. These shares of phantom stock will become payable in cash to the reporting person upon separation from service as a director in accordance with the reporting person's election under the Directors Deferred Compensation Plan.

F1 · derivative.expiration_date: Represents dividend equivalent phantom shares accrued on previously awarded phantom shares in accordance with the terms of the Directors Deferred Compensation Plan. Each share of phantom stock is the economic equivalent of one share of common stock. These shares of phantom stock will become payable in cash to the reporting person upon separation from service as a director in accordance with the reporting person's election under the Directors Deferred Compensation Plan.

Read SEC document
January 03, 2023 Filed Jan 4, 2023 23:34 UTC RESOURCES CONNECTION, INC. RGP · Entity 6553 GrantPhantom Stock · Derivative 5,393 $0.00 $0.00
Disclosure

SEC source: 0001248380-23-000002 · edgardoc.xml · derivative · entry 1

DIMICK NEIL F · CIK 0001248380 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 42,533

Underlying: Common Stock · 5,393 shares

Expires not disclosed

F1 · derivative.exercise_price: Award vests 25% after one year and 25% each year thereafter for the next three years. Represents credit of deferred compensation to reporting person's deferred stock account under the Directors Deferred Compensation Plan. Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock to the extent then-vested become payable in cash to the reporting person upon separation from service as a director in accordance with the reporting person's election under the Directors Deferred Compensation Plan.

F1 · derivative.exercise_date: Award vests 25% after one year and 25% each year thereafter for the next three years. Represents credit of deferred compensation to reporting person's deferred stock account under the Directors Deferred Compensation Plan. Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock to the extent then-vested become payable in cash to the reporting person upon separation from service as a director in accordance with the reporting person's election under the Directors Deferred Compensation Plan.

F1 · derivative.expiration_date: Award vests 25% after one year and 25% each year thereafter for the next three years. Represents credit of deferred compensation to reporting person's deferred stock account under the Directors Deferred Compensation Plan. Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock to the extent then-vested become payable in cash to the reporting person upon separation from service as a director in accordance with the reporting person's election under the Directors Deferred Compensation Plan.

F2 · balance_after: Includes 3,856 phantom shares credited as dividend equivalent phantom shares in accordance with the terms of the Directors Deferred Compensation Plan.

Read SEC document
March 21, 2022 Filed Mar 23, 2022 19:00 UTC Viatris Inc VTRS · Entity 3277 Exercise / conversionDividend Equivalent Units · Derivative 165.5224 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0000899243-22-011982 · doc4.xml · derivative · entry 3

DIMICK NEIL F · CIK 0001248380 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 165.5224 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: Represents dividend equivalent units (DEUs) that accrued with respect to RSUs previously granted on March 2, 2021. The DEUs vested upon accrual as the underlying RSUs had previously vested.

F3 · derivative.expiration_date: Represents dividend equivalent units (DEUs) that accrued with respect to RSUs previously granted on March 2, 2021. The DEUs vested upon accrual as the underlying RSUs had previously vested.

Read SEC document
March 21, 2022 Filed Mar 23, 2022 19:00 UTC Viatris Inc VTRS · Entity 3277 GrantDividend Equivalent Units · Derivative 165.5224 $0.00 $0.00
Disclosure

SEC source: 0000899243-22-011982 · doc4.xml · derivative · entry 2

DIMICK NEIL F · CIK 0001248380 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 165.5224

Underlying: Common Stock · 165.5224 shares

Expires not disclosed

F3 · derivative.exercise_price: Represents dividend equivalent units (DEUs) that accrued with respect to RSUs previously granted on March 2, 2021. The DEUs vested upon accrual as the underlying RSUs had previously vested.

F3 · derivative.exercise_date: Represents dividend equivalent units (DEUs) that accrued with respect to RSUs previously granted on March 2, 2021. The DEUs vested upon accrual as the underlying RSUs had previously vested.

F3 · derivative.expiration_date: Represents dividend equivalent units (DEUs) that accrued with respect to RSUs previously granted on March 2, 2021. The DEUs vested upon accrual as the underlying RSUs had previously vested.

Read SEC document
March 21, 2022 Filed Mar 23, 2022 19:00 UTC Viatris Inc VTRS · Entity 3277 Exercise / conversionCommon Stock 166 $0.00 $0.00
Disclosure

SEC source: 0000899243-22-011982 · doc4.xml · nonDerivative · entry 1

DIMICK NEIL F · CIK 0001248380 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 75,200

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Fractional shares have been rounded up in connection with the settlement described in footnote 2 pursuant to the terms of the restricted stock unit (RSU) award agreement under the Viatris Inc. 2020 Stock Incentive Plan.

F2 · balance_after: The total reported in Column 5 has been adjusted by 30 shares to correct an understatement of total holdings first reflected in the reporting person's Form 4 filed on March 4, 2022.

Read SEC document
March 04, 2022 Filed Mar 4, 2022 19:58 UTC Viatris Inc VTRS · Entity 3277 GrantRestricted Stock Units · Derivative 19,608 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0000899243-22-009530 · doc4.xml · derivative · entry 5

DIMICK NEIL F · CIK 0001248380 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,608

Underlying: Common Stock · 19,608 shares

Expires not disclosed

F4 · derivative.exercise_date: Each RSU represents the right to receive one share of common stock of Viatris. These RSUs will vest on March 4, 2023.

F4 · derivative.expiration_date: Each RSU represents the right to receive one share of common stock of Viatris. These RSUs will vest on March 4, 2023.

Read SEC document
March 02, 2022 Filed Mar 4, 2022 19:58 UTC Viatris Inc VTRS · Entity 3277 Exercise / conversionDividend Equivalent Units · Derivative 334.4826 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0000899243-22-009530 · doc4.xml · derivative · entry 4

DIMICK NEIL F · CIK 0001248380 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 334.4826 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: Represents dividend equivalent units that accrued with respect to the RSUs previously granted on March 2, 2021 and vested on the same schedule as the underlying RSUs.

F3 · derivative.expiration_date: Represents dividend equivalent units that accrued with respect to the RSUs previously granted on March 2, 2021 and vested on the same schedule as the underlying RSUs.

Read SEC document
March 02, 2022 Filed Mar 4, 2022 19:58 UTC Viatris Inc VTRS · Entity 3277 Exercise / conversionRestricted Stock Units · Derivative 13,996 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0000899243-22-009530 · doc4.xml · derivative · entry 3

DIMICK NEIL F · CIK 0001248380 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 13,996 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: Each RSU represents the right to receive one share of common stock of Viatris Inc. (Viatris). These RSUs vested in full on March 2, 2022.

F2 · derivative.expiration_date: Each RSU represents the right to receive one share of common stock of Viatris Inc. (Viatris). These RSUs vested in full on March 2, 2022.

Read SEC document
March 02, 2022 Filed Mar 4, 2022 19:58 UTC Viatris Inc VTRS · Entity 3277 Exercise / conversionCommon Stock 335 $0.00 $0.00
Disclosure

SEC source: 0000899243-22-009530 · doc4.xml · nonDerivative · entry 2

DIMICK NEIL F · CIK 0001248380 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 75,004

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Fractional shares have been rounded up in connection with the settlement described in footnote 3 pursuant to the terms of the restricted stock unit (RSU) award agreement under the Viatris Inc. 2020 Stock Incentive Plan.

Read SEC document
March 02, 2022 Filed Mar 4, 2022 19:58 UTC Viatris Inc VTRS · Entity 3277 Exercise / conversionCommon Stock 13,996 $0.00 $0.00
Disclosure

SEC source: 0000899243-22-009530 · doc4.xml · nonDerivative · entry 1

DIMICK NEIL F · CIK 0001248380 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 74,669

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
January 03, 2022 Filed Jan 5, 2022 22:05 UTC RESOURCES CONNECTION, INC. RGP · Entity 6553 GrantPhantom Stock · Derivative 5,534 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001248380-22-000002 · edgardoc.xml · derivative · entry 1

DIMICK NEIL F · CIK 0001248380 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 33,284

Underlying: Common Stock · 5,534 shares

Expires not disclosed

F1 · derivative.exercise_date: Award vests 25% after one year and 25% each year thereafter for the next three years. Represents credit of deferred compensation to reporting person's deferred stock account under the Directors Deferred Compensation Plan. Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock to the extent then-vested become payable in cash to the reporting person upon separation from service as a director in accordance with the reporting person's election under the Directors Deferred Compensation Plan.

F1 · derivative.expiration_date: Award vests 25% after one year and 25% each year thereafter for the next three years. Represents credit of deferred compensation to reporting person's deferred stock account under the Directors Deferred Compensation Plan. Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock to the extent then-vested become payable in cash to the reporting person upon separation from service as a director in accordance with the reporting person's election under the Directors Deferred Compensation Plan.

Read SEC document
December 21, 2021 Filed Dec 23, 2021 18:01 UTC Viatris Inc VTRS · Entity 3277 GrantDividend Equivalent Units · Derivative 120.0574 $0.00 $0.00
Disclosure

SEC source: 0000899243-21-049647 · doc4.xml · derivative · entry 1

DIMICK NEIL F · CIK 0001248380 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 334.4826

Underlying: Common Stock · 120.0574 shares

Expires not disclosed

F1 · derivative.exercise_price: Represents dividend equivalent units ("DEUs") that accrued with respect to restricted stock units ("RSUs") previously granted on March 2, 2021 and vest on the same schedule as the underlying RSUs.

F1 · derivative.exercise_date: Represents dividend equivalent units ("DEUs") that accrued with respect to restricted stock units ("RSUs") previously granted on March 2, 2021 and vest on the same schedule as the underlying RSUs.

F1 · derivative.expiration_date: Represents dividend equivalent units ("DEUs") that accrued with respect to restricted stock units ("RSUs") previously granted on March 2, 2021 and vest on the same schedule as the underlying RSUs.

Read SEC document
September 22, 2021 Filed Sep 24, 2021 18:01 UTC Viatris Inc VTRS · Entity 3277 GrantDividend Equivalent Units · Derivative 113.2715 $0.00 $0.00
Disclosure

SEC source: 0000899243-21-037660 · doc4.xml · derivative · entry 1

DIMICK NEIL F · CIK 0001248380 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 214.4252

Underlying: Common Stock · 113.2715 shares

Expires not disclosed

F1 · derivative.exercise_price: Represents dividend equivalent units ("DEUs") that accrued with respect to restricted stock units ("RSUs") previously granted on March 2, 2021 and vest on the same schedule as the underlying RSUs.

F1 · derivative.exercise_date: Represents dividend equivalent units ("DEUs") that accrued with respect to restricted stock units ("RSUs") previously granted on March 2, 2021 and vest on the same schedule as the underlying RSUs.

F1 · derivative.expiration_date: Represents dividend equivalent units ("DEUs") that accrued with respect to restricted stock units ("RSUs") previously granted on March 2, 2021 and vest on the same schedule as the underlying RSUs.

Read SEC document
June 21, 2021 Filed Jun 23, 2021 20:30 UTC Viatris Inc VTRS · Entity 3277 GrantDividend Equivalent Units · Derivative 101.1537 $0.00 $0.00
Disclosure

SEC source: 0000899243-21-025577 · doc4.xml · derivative · entry 1

DIMICK NEIL F · CIK 0001248380 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 101.1537

Underlying: Common Stock · 101.1537 shares

Expires not disclosed

F1 · derivative.exercise_price: Represents dividend equivalent units ("DEUs") that accrued with respect to restricted stock units ("RSUs") previously granted on March 2, 2021 and vest on the same schedule as the underlying RSUs.

F1 · derivative.exercise_date: Represents dividend equivalent units ("DEUs") that accrued with respect to restricted stock units ("RSUs") previously granted on March 2, 2021 and vest on the same schedule as the underlying RSUs.

F1 · derivative.expiration_date: Represents dividend equivalent units ("DEUs") that accrued with respect to restricted stock units ("RSUs") previously granted on March 2, 2021 and vest on the same schedule as the underlying RSUs.

Read SEC document
March 02, 2021 Filed Mar 4, 2021 18:35 UTC Viatris Inc VTRS · Entity 3277 Exercise / conversionRestricted Stock Units · Derivative 9,440 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0000899243-21-009924 · doc4.xml · derivative · entry 3

DIMICK NEIL F · CIK 0001248380 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 9,440 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: Each RSU represents the right to receive one share of common stock of Viatris. These RSUs vested in full on March 2, 2021.

F2 · derivative.expiration_date: Each RSU represents the right to receive one share of common stock of Viatris. These RSUs vested in full on March 2, 2021.

Read SEC document
March 02, 2021 Filed Mar 4, 2021 18:35 UTC Viatris Inc VTRS · Entity 3277 GrantRestricted Stock Units · Derivative 13,996 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0000899243-21-009924 · doc4.xml · derivative · entry 2

DIMICK NEIL F · CIK 0001248380 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,996

Underlying: Common Stock · 13,996 shares

Expires not disclosed

F1 · derivative.exercise_date: Each restricted stock unit (RSU) represents the right to receive one share of common stock of Viatris Inc. ("Viatris"). These RSUs will vest on March 2, 2022.

F1 · derivative.expiration_date: Each restricted stock unit (RSU) represents the right to receive one share of common stock of Viatris Inc. ("Viatris"). These RSUs will vest on March 2, 2022.

Read SEC document
March 02, 2021 Filed Mar 4, 2021 18:35 UTC Viatris Inc VTRS · Entity 3277 Exercise / conversionCommon Stock 9,440 $0.00 $0.00
Disclosure

SEC source: 0000899243-21-009924 · doc4.xml · nonDerivative · entry 1

DIMICK NEIL F · CIK 0001248380 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 60,703

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
January 04, 2021 Filed Jan 6, 2021 02:32 UTC RESOURCES CONNECTION, INC. RGP · Entity 6553 GrantPhantom Stock · Derivative 8,058 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001248380-21-000002 · edgardoc.xml · derivative · entry 1

DIMICK NEIL F · CIK 0001248380 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 27,750

Underlying: Common Stock · 8,058 shares

Expires not disclosed

F1 · derivative.exercise_date: Represents credit of deferred compensation to reporting person's deferred stock account under the Directors Deferred Compensation Plan. Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in cash to the reporting person upon separation from service as a director.

F1 · derivative.expiration_date: Represents credit of deferred compensation to reporting person's deferred stock account under the Directors Deferred Compensation Plan. Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in cash to the reporting person upon separation from service as a director.

Read SEC document
November 16, 2020 Filed Nov 18, 2020 19:53 UTC Viatris Inc VTRS · Entity 3277 GrantRestricted Stock Units · Derivative 9,440 Not disclosed Strike: $0.00 Not disclosed
Disclosure

SEC source: 0000899243-20-031577 · doc4.xml · derivative · entry 9

DIMICK NEIL F · CIK 0001248380 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,440

Underlying: Common Stock · 9,440 shares

Expires not disclosed

F11 · security: Received in exchange for, and having substantially the same terms as, restricted stock units ("RSUs") of Mylan in connection with the Combination.

F11 · price: Received in exchange for, and having substantially the same terms as, restricted stock units ("RSUs") of Mylan in connection with the Combination.

F12 · derivative.exercise_date: Each RSU represents the right to receive one share of common stock of Viatris. The RSUs will vest on March 2, 2021.

F12 · derivative.expiration_date: Each RSU represents the right to receive one share of common stock of Viatris. The RSUs will vest on March 2, 2021.

Read SEC document
November 16, 2020 Filed Nov 18, 2020 19:53 UTC Viatris Inc VTRS · Entity 3277 GrantNon-Employee Director Stock Option - Right to Buy · Derivative 6,151 Not disclosed Strike: $17.48 Not disclosed
Disclosure

SEC source: 0000899243-20-031577 · doc4.xml · derivative · entry 8

DIMICK NEIL F · CIK 0001248380 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,151

Underlying: Common Stock · 6,151 shares

Expires 2030-03-02

F3 · security: Received in exchange for, and having substantially the same terms as, stock options to acquire Mylan ordinary shares in connection with the Combination.

F3 · price: Received in exchange for, and having substantially the same terms as, stock options to acquire Mylan ordinary shares in connection with the Combination.

F10 · derivative.exercise_date: These options will vest on March 2, 2021

Read SEC document
November 16, 2020 Filed Nov 18, 2020 19:53 UTC Viatris Inc VTRS · Entity 3277 GrantNon-Employee Director Stock Option - Right to Buy · Derivative 4,352 Not disclosed Strike: $27.45 Not disclosed
Disclosure

SEC source: 0000899243-20-031577 · doc4.xml · derivative · entry 7

DIMICK NEIL F · CIK 0001248380 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,352

Underlying: Common Stock · 4,352 shares

Expires 2029-03-01

F3 · security: Received in exchange for, and having substantially the same terms as, stock options to acquire Mylan ordinary shares in connection with the Combination.

F3 · price: Received in exchange for, and having substantially the same terms as, stock options to acquire Mylan ordinary shares in connection with the Combination.

F9 · derivative.exercise_date: These options vested on March 2, 2020.

Read SEC document
November 16, 2020 Filed Nov 18, 2020 19:53 UTC Viatris Inc VTRS · Entity 3277 GrantNon-Employee Director Stock Option - Right to Buy · Derivative 2,984 Not disclosed Strike: $40.97 Not disclosed
Disclosure

SEC source: 0000899243-20-031577 · doc4.xml · derivative · entry 6

DIMICK NEIL F · CIK 0001248380 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,984

Underlying: Common Stock · 2,984 shares

Expires 2028-03-02

F3 · security: Received in exchange for, and having substantially the same terms as, stock options to acquire Mylan ordinary shares in connection with the Combination.

F3 · price: Received in exchange for, and having substantially the same terms as, stock options to acquire Mylan ordinary shares in connection with the Combination.

F8 · derivative.exercise_date: These options vested on March 2, 2019.

Read SEC document
November 16, 2020 Filed Nov 18, 2020 19:53 UTC Viatris Inc VTRS · Entity 3277 GrantNon-Employee Director Stock Option - Right to Buy · Derivative 2,928 Not disclosed Strike: $45.18 Not disclosed
Disclosure

SEC source: 0000899243-20-031577 · doc4.xml · derivative · entry 5

DIMICK NEIL F · CIK 0001248380 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,928

Underlying: Common Stock · 2,928 shares

Expires 2027-03-03

F3 · security: Received in exchange for, and having substantially the same terms as, stock options to acquire Mylan ordinary shares in connection with the Combination.

F3 · price: Received in exchange for, and having substantially the same terms as, stock options to acquire Mylan ordinary shares in connection with the Combination.

F7 · derivative.exercise_date: These options vested on March 3, 2018.

Read SEC document
November 16, 2020 Filed Nov 18, 2020 19:53 UTC Viatris Inc VTRS · Entity 3277 GrantNon-Employee Director Stock Option - Right to Buy · Derivative 2,788 Not disclosed Strike: $46.27 Not disclosed
Disclosure

SEC source: 0000899243-20-031577 · doc4.xml · derivative · entry 4

DIMICK NEIL F · CIK 0001248380 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,788

Underlying: Common Stock · 2,788 shares

Expires 2026-02-17

F3 · security: Received in exchange for, and having substantially the same terms as, stock options to acquire Mylan ordinary shares in connection with the Combination.

F3 · price: Received in exchange for, and having substantially the same terms as, stock options to acquire Mylan ordinary shares in connection with the Combination.

F6 · derivative.exercise_date: These options vested on February 17, 2017.

Read SEC document
November 16, 2020 Filed Nov 18, 2020 19:53 UTC Viatris Inc VTRS · Entity 3277 GrantNon-Employee Director Stock Option - Right to Buy · Derivative 2,603 Not disclosed Strike: $50.66 Not disclosed
Disclosure

SEC source: 0000899243-20-031577 · doc4.xml · derivative · entry 3

DIMICK NEIL F · CIK 0001248380 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,603

Underlying: Common Stock · 2,603 shares

Expires 2025-11-17

F3 · security: Received in exchange for, and having substantially the same terms as, stock options to acquire Mylan ordinary shares in connection with the Combination.

F3 · price: Received in exchange for, and having substantially the same terms as, stock options to acquire Mylan ordinary shares in connection with the Combination.

F5 · derivative.exercise_date: These options vested on May 1, 2016.

Read SEC document
November 16, 2020 Filed Nov 18, 2020 19:53 UTC Viatris Inc VTRS · Entity 3277 GrantNon-Employee Director Stock Option - Right to Buy · Derivative 2,974 Not disclosed Strike: $45.72 Not disclosed
Disclosure

SEC source: 0000899243-20-031577 · doc4.xml · derivative · entry 2

DIMICK NEIL F · CIK 0001248380 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,974

Underlying: Common Stock · 2,974 shares

Expires 2024-04-11

F3 · security: Received in exchange for, and having substantially the same terms as, stock options to acquire Mylan ordinary shares in connection with the Combination.

F3 · price: Received in exchange for, and having substantially the same terms as, stock options to acquire Mylan ordinary shares in connection with the Combination.

F4 · derivative.exercise_date: These options vested on April 11, 2015.

Read SEC document
November 16, 2020 Filed Nov 18, 2020 19:53 UTC Viatris Inc VTRS · Entity 3277 GrantCommon Stock 51,263 Not disclosed Not disclosed
Disclosure

SEC source: 0000899243-20-031577 · doc4.xml · nonDerivative · entry 1

DIMICK NEIL F · CIK 0001248380 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 51,263

F1 · security: On November 16, 2020, Mylan N.V. ("Mylan") completed the transaction pursuant to which Mylan combined with Pfizer Inc.'s ("Pfizer") Upjohn business (the "Upjohn Business") in a Reverse Morris Trust transaction (the "Combination") and Upjohn Inc. ("Upjohn") became the parent entity of the combined Upjohn Business and Mylan business and was renamed "Viatris Inc." ("Viatris"). Pursuant to the terms of the Business Combination Agreement (as amended), dated July 29, 2019, by and among Mylan, Pfizer, Upjohn and certain other affiliated entities, Upjohn and Mylan effected the Combination through a series of transactions, including that each holder of Mylan ordinary shares received one share of Viatris common stock for each Mylan ordinary share held by such holder (subject to any required withholding tax).

F2 · price: Represents shares of Viatris common stock acquired in connection with the Combination on a one-for-one basis in exchange for ordinary shares of Mylan. On the effective date of the Combination, the closing price of a Mylan ordinary share was $15.85 per share.

Read SEC document
November 16, 2020 Filed Nov 18, 2020 19:20 UTC Mylan II B.V. MYL · Entity 16217 Disposition to issuerRestricted Stock Units · Derivative 9,440 Not disclosed Strike: $0.00 Not disclosed
Disclosure

SEC source: 0000899243-20-031512 · doc4.xml · derivative · entry 9

DIMICK NEIL F · CIK 0001248380 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Ordinary Shares · 9,440 shares

Expires not disclosed

F11 · security: Represents restricted stock units ("RSUs") of Mylan that were exchanged on a one-for-one basis for RSUs of Viatris having substantially the same terms in connection with the Combination.

F11 · price: Represents restricted stock units ("RSUs") of Mylan that were exchanged on a one-for-one basis for RSUs of Viatris having substantially the same terms in connection with the Combination.

F12 · derivative.exercise_date: Each RSU represents the right to receive one ordinary share of Mylan. The RSUs will vest on March 2, 2021.

F12 · derivative.expiration_date: Each RSU represents the right to receive one ordinary share of Mylan. The RSUs will vest on March 2, 2021.

Read SEC document
November 16, 2020 Filed Nov 18, 2020 19:20 UTC Mylan II B.V. MYL · Entity 16217 Disposition to issuerNon-Employee Director Stock Option - Right to Buy · Derivative 6,151 Not disclosed Strike: $17.48 Not disclosed
Disclosure

SEC source: 0000899243-20-031512 · doc4.xml · derivative · entry 8

DIMICK NEIL F · CIK 0001248380 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Ordinary Shares · 6,151 shares

Expires 2030-03-02

F3 · security: Represents stock options to acquire Mylan ordinary shares that were exchanged for stock options to acquire Viatris common stock having substantially the same terms in connection with the Combination.

F3 · price: Represents stock options to acquire Mylan ordinary shares that were exchanged for stock options to acquire Viatris common stock having substantially the same terms in connection with the Combination.

F10 · derivative.exercise_date: These options will vest on March 2, 2021.

Read SEC document
November 16, 2020 Filed Nov 18, 2020 19:20 UTC Mylan II B.V. MYL · Entity 16217 Disposition to issuerNon-Employee Director Stock Option - Right to Buy · Derivative 4,352 Not disclosed Strike: $27.45 Not disclosed
Disclosure

SEC source: 0000899243-20-031512 · doc4.xml · derivative · entry 7

DIMICK NEIL F · CIK 0001248380 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Ordinary Shares · 4,352 shares

Expires 2029-03-01

F3 · security: Represents stock options to acquire Mylan ordinary shares that were exchanged for stock options to acquire Viatris common stock having substantially the same terms in connection with the Combination.

F3 · price: Represents stock options to acquire Mylan ordinary shares that were exchanged for stock options to acquire Viatris common stock having substantially the same terms in connection with the Combination.

F9 · derivative.exercise_date: These options vested on March 2, 2020.

Read SEC document
November 16, 2020 Filed Nov 18, 2020 19:20 UTC Mylan II B.V. MYL · Entity 16217 Disposition to issuerNon-Employee Director Stock Option - Right to Buy · Derivative 2,984 Not disclosed Strike: $40.97 Not disclosed
Disclosure

SEC source: 0000899243-20-031512 · doc4.xml · derivative · entry 6

DIMICK NEIL F · CIK 0001248380 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Ordinary Shares · 2,984 shares

Expires 2028-03-02

F3 · security: Represents stock options to acquire Mylan ordinary shares that were exchanged for stock options to acquire Viatris common stock having substantially the same terms in connection with the Combination.

F3 · price: Represents stock options to acquire Mylan ordinary shares that were exchanged for stock options to acquire Viatris common stock having substantially the same terms in connection with the Combination.

F8 · derivative.exercise_date: These options vested on March 2, 2019.

Read SEC document
November 16, 2020 Filed Nov 18, 2020 19:20 UTC Mylan II B.V. MYL · Entity 16217 Disposition to issuerNon-Employee Director Stock Option - Right to Buy · Derivative 2,928 Not disclosed Strike: $45.18 Not disclosed
Disclosure

SEC source: 0000899243-20-031512 · doc4.xml · derivative · entry 5

DIMICK NEIL F · CIK 0001248380 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Ordinary Shares · 2,928 shares

Expires 2027-03-03

F3 · security: Represents stock options to acquire Mylan ordinary shares that were exchanged for stock options to acquire Viatris common stock having substantially the same terms in connection with the Combination.

F3 · price: Represents stock options to acquire Mylan ordinary shares that were exchanged for stock options to acquire Viatris common stock having substantially the same terms in connection with the Combination.

F7 · derivative.exercise_date: These options vested on March 3, 2018.

Read SEC document
November 16, 2020 Filed Nov 18, 2020 19:20 UTC Mylan II B.V. MYL · Entity 16217 Disposition to issuerNon-Employee Director Stock Option - Right to Buy · Derivative 2,788 Not disclosed Strike: $46.27 Not disclosed
Disclosure

SEC source: 0000899243-20-031512 · doc4.xml · derivative · entry 4

DIMICK NEIL F · CIK 0001248380 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Ordinary Shares · 2,788 shares

Expires 2026-02-17

F3 · security: Represents stock options to acquire Mylan ordinary shares that were exchanged for stock options to acquire Viatris common stock having substantially the same terms in connection with the Combination.

F3 · price: Represents stock options to acquire Mylan ordinary shares that were exchanged for stock options to acquire Viatris common stock having substantially the same terms in connection with the Combination.

F6 · derivative.exercise_date: These options vested on February 17, 2017.

Read SEC document
November 16, 2020 Filed Nov 18, 2020 19:20 UTC Mylan II B.V. MYL · Entity 16217 Disposition to issuerNon-Employee Director Stock Option - Right to Buy · Derivative 2,603 Not disclosed Strike: $50.66 Not disclosed
Disclosure

SEC source: 0000899243-20-031512 · doc4.xml · derivative · entry 3

DIMICK NEIL F · CIK 0001248380 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Ordinary Shares · 2,603 shares

Expires 2025-11-17

F3 · security: Represents stock options to acquire Mylan ordinary shares that were exchanged for stock options to acquire Viatris common stock having substantially the same terms in connection with the Combination.

F3 · price: Represents stock options to acquire Mylan ordinary shares that were exchanged for stock options to acquire Viatris common stock having substantially the same terms in connection with the Combination.

F5 · derivative.exercise_date: These options vested on May 1, 2016.

Read SEC document
November 16, 2020 Filed Nov 18, 2020 19:20 UTC Mylan II B.V. MYL · Entity 16217 Disposition to issuerNon-Employee Director Stock Option - Right to Buy · Derivative 2,974 Not disclosed Strike: $45.72 Not disclosed
Disclosure

SEC source: 0000899243-20-031512 · doc4.xml · derivative · entry 2

DIMICK NEIL F · CIK 0001248380 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Ordinary Shares · 2,974 shares

Expires 2024-04-11

F3 · security: Represents stock options to acquire Mylan ordinary shares that were exchanged for stock options to acquire Viatris common stock having substantially the same terms in connection with the Combination.

F3 · price: Represents stock options to acquire Mylan ordinary shares that were exchanged for stock options to acquire Viatris common stock having substantially the same terms in connection with the Combination.

F4 · derivative.exercise_date: These options vested on April 11, 2015.

Read SEC document
November 16, 2020 Filed Nov 18, 2020 19:20 UTC Mylan II B.V. MYL · Entity 16217 Disposition to issuerOrdinary Shares 51,263 Not disclosed Not disclosed
Disclosure

SEC source: 0000899243-20-031512 · doc4.xml · nonDerivative · entry 1

DIMICK NEIL F · CIK 0001248380 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F1 · security: On November 16, 2020, Mylan N.V. ("Mylan") completed the transaction pursuant to which Mylan combined with Pfizer Inc.'s ("Pfizer") Upjohn business (the "Upjohn Business") in a Reverse Morris Trust transaction (the "Combination") and Upjohn Inc. ("Upjohn") became the parent entity of the combined Upjohn Business and Mylan business and was renamed "Viatris Inc." ("Viatris"). Pursuant to the terms of the Business Combination Agreement (as amended), dated July 29, 2019, by and among Mylan, Pfizer, Upjohn and certain other affiliated entities, Upjohn and Mylan effected the Combination through a series of transactions, including that (1) Mylan merged with and into Mylan II B.V. with Mylan II B.V. surviving the merger as the legal successor of Mylan and (2) each holder of Mylan ordinary shares received one share of Viatris common stock for each Mylan ordinary share held by such holder (subject to any required withholding tax).

F2 · price: Represents ordinary shares of Mylan that were exchanged on a one-for-one basis for shares of Viatris common stock in connection with the Combination. On the effective date of the Combination, the closing price of a Mylan ordinary share was $15.85 per share.

Read SEC document
March 02, 2020 Filed Mar 4, 2020 18:32 UTC Mylan II B.V. MYL · Entity 16217 Exercise / conversionRestricted Stock Units · Derivative 6,011 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0000899243-20-007020 · doc4.xml · derivative · entry 5

DIMICK NEIL F · CIK 0001248380 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Ordinary Shares · 6,011 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: Each RSU represents the right to receive one ordinary share of Mylan N.V. These RSUs vested in full on March 2, 2020.

F4 · derivative.expiration_date: Each RSU represents the right to receive one ordinary share of Mylan N.V. These RSUs vested in full on March 2, 2020.

Read SEC document
March 02, 2020 Filed Mar 4, 2020 18:32 UTC Mylan II B.V. MYL · Entity 16217 GrantRestricted Stock Units · Derivative 9,440 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0000899243-20-007020 · doc4.xml · derivative · entry 4

DIMICK NEIL F · CIK 0001248380 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,440

Underlying: Ordinary Shares · 9,440 shares

Expires not disclosed

F3 · derivative.exercise_date: Each RSU represents the right to receive one ordinary share of Mylan N.V. These RSUs will vest in full on March 2, 2021.

F3 · derivative.expiration_date: Each RSU represents the right to receive one ordinary share of Mylan N.V. These RSUs will vest in full on March 2, 2021.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.